Companies

amino-acid complexes of zinc, manganese, copper and cobalt, with several SKUs OMRI-listed for certified-organic production.

its competing Sexcel technology uses targeted laser pulses in microfluidic chips to inactivate Y-chromosome sperm motility without physical fraction separation, a gentler process that improves X-sperm survival and is widely applied across the US dairy herd.

together process a large share of the roughly $18.6 billion 2025 US deep-grain-processing market, with ADM's Q1 2026 results highlighting its Carbohydrate Solutions segment alongside new plant-based ingredient launches (ProFam soy isolates, Arcon soy concentrates) in May 2026.

Zero-Tailings™ bioleaching — Ecuador 50 t/day facility, fertilizer co-production, patents filed (2026).

Alternative-protein health risk assessment — Feeds national biotech4proteins innovation-hub funding.

a bioeconomy consulting firm specializing in transforming agricultural waste into valuable products, focusing on waste-management innovation, resource efficiency and circular-economy adoption for clients navigating the petro-to-bio transition.

markets Terra-Sorb SymBiotic, its first microbial biostimulant, built around the Bacillus velezensis strain PH-023 and the company's Priming Tech platform combining biostimulation with biofertilization.

launched BeCrop 4.0 in March 2026, improving DNA taxonomic assignment precision by over 30% and identifying more than 44,550 fungal species for better detection of beneficial and pathogenic organisms.

a Spanish neurotechnology company blending neuroscience, AI and hardware into BCI products, has applied its wearable EEG systems to projects including Nissan's brain-to-vehicle research, alongside wellness and cognitive-research applications.

received a June 2026 environmental court permit for continued and expanded mining activity at its Aitik mine in Sweden, with conditions addressing water and air emissions as part of its broader base-metal and precious-metal production operations.

continues advancing its proprietary mRNA vaccine platform, reporting Phase II safety and immunogenicity data for its CS-2034 mRNA vaccine in Chinese adults, building on its earlier position as a global pioneer of adenoviral-vector vaccines.

operates a neutral, curated platform accelerating biomanufacturing partnerships by mapping real capabilities and coordinating execution across discovery, development and GMP; its live "active CDMO programs" directory (June 2026) lists anonymized sponsor demand by modality, scope and development stage.

GFP-Trap, RFP-Trap, Spot-Tag — Nanobody-based affinity purification, antibody-free IP.

CME Group listed new futures contracts in 2026 including Chicago Ethanol (Platts) BALMO futures and Gulf Coast CBOB Gasoline futures, extending its existing renewable-diesel and SAF Book-and-Claim swap products integrated with the M-RETS system and EPA RFS RIN registries.

markets a broad hydrocolloid portfolio spanning pectins, xanthan and gellan gum, serving food, pharmaceutical and industrial customers amid a mature but steadily growing global hydrocolloids market.

operates a network of more than 200 independent regulatory consultants providing 21 CFR Part 111 GMP audit preparation, batch-record development and labeling-compliance review across dietary supplements, food, drugs, medical devices and cosmetics.

Naia Lyte acetate filament — Higher-tenacity cellulose acetate yarn (2026).

has parlayed its GLP-1 dual-agonist tirzepatide (Mounjaro/Zepbound) into a broader portfolio strategy spanning diabetes, obesity and expanded cardiometabolic indications, reinforcing its position at the January 2026 JPMorgan Healthcare Conference even amid looming patent challenges.

offers full-service microbial CDMO solutions for foodtech and synthetic biology, including recombinant food proteins (caseins, whey proteins) and non-standard fermentation platforms such as the anaerobic acetogen Acetobacterium woodii for precision carbon conversion.

Interaxon's Muse completed its "Sleep, by Design" platform in April 2026 with Smart Wakeup, a brain-guided alarm using real-time EEG to detect light sleep; Emotiv continues to sell its Insight and EPOC X headsets to both consumer and BCI-developer markets.

produces expanded foam solutions for furniture and personal well-being applications, including high-performance viscoelastic materials using advanced processing techniques and certifications.

built on Steven Benner's Hachimoji eight-letter DNA/RNA system, contributed to a June 2026 Nature Communications study expanding triplex-forming oligonucleotide DNA recognition using the expanded genetic alphabet (AEGIS) for programmable, sequence-specific applications.

Rimisoxafen, Tremisia seed-applied chemistry — Expanding herbicide/fungicide license agreements (2025-2026).

Aequival 2'-FL — Thailand infant/follow-on formula approval.

announced in December 2024 the availability for licensing of its commercial high-titer HMO production strains and IP covering prebiotic, anti-inflammatory and anti-infective uses, with strains validated at large fermentation scale for 2'-FL, LNT, 3'-SL and 6'-SL.

established by State Council approval in 2013 and covering roughly 20 square kilometers near the Boao Forum for Asia, the zone lets foreign innovative cell therapies and medical devices treat patients before their nationwide China registration, drawing thousands of international patients and physicians.

through its NIFA Technologies subsidiary (part of the group since 2010, originally founded in 1948), is a world leader in semen packaging, cryopreservation and Computer Assisted Semen Analysis (CASA) equipment, supplying laboratories worldwide.

markets functional native starches such as NOVATION Indulge, a clean-label, non-GMO corn starch for gelling and film-forming applications in dairy and dairy-alternative products.

Muse S headband, Smart Wakeup — Brain-guided sleep alarm, "Sleep, by Design" platform (2026).

develops custom endophyte formulations that colonize plants to fix atmospheric nitrogen and improve phosphorus and micronutrient uptake, and was acquired by Syngenta Biologicals in a deal reported in May 2026, strengthening the combined company's biological nutrient-efficiency portfolio.

producing jellyfish-derived Collagen Type Zero, formed a strategic partnership with US-based Royal Biologics in early 2026 to commercialize the material for the North American regenerative-medicine market, covering wound care and tissue-engineering applications.

develops animal-free gelatin and collagen targeting confectionery and pharmaceutical capsule applications, backed in part by CULT Food Science's venture arm and included in a Bezos Earth Fund-backed sustainable-protein research center at North Carolina State University.

the institution's food science faculty continues to publish leading gellan gum research, including a March 2026 Carbohydrate Polymers review on the formation mechanisms, analysis strategies and regulation of gellan gum-based films, reflecting its position as a global center for hydrocolloid fermentation research.

markets a range of xanthan gum grades tailored for food, cosmetic/pharmaceutical and industrial applications, emphasizing high viscosity at low concentrations and stability across processing conditions, alongside its broader citric-acid fermentation business.

Piet Herdewijn's group published structural work on a Thermococcus kodakarensis DNA polymerase (KOD-H4) engineered for HNA (hexose nucleic acid) reverse transcription, providing the first structural insight into how a DNA polymerase processes a xeno-nucleic acid backbone.

its GreenFlex Foam, a plant-based foam developed in-house, is now used across most of the company's mattress lineup, reflecting bio-based foam's move into mainstream direct-to-consumer bedding.

launched its TENCEL Lyocell HV100 fiber in China at Intertextile Shanghai in March 2026, using Variocut technology to create controlled staple-length variation for a natural, matte, textured hand, expanding the brand from denim into broader woven apparel markets.

its EcoSphere Bio-Based Foam for automotive seating uses processed plant-based polyols to reach up to 20% renewable content, combining bio-based and recycled inputs while meeting OEM performance and manufacturability requirements.

hosted its Porcine TechDays 2026 conference in June, drawing roughly 80 in-person attendees and numerous virtual participants to discuss advances in swine reproductive efficiency, alongside its fully robotic semen packaging and freezing lines for cattle and swine.

developed MinBind, a non-organic binder that improves permeability and reduces slumping in heap leaching of low-grade, low-permeability ore from 10-15% down to lower rates, announced in May 2026, unlocking value from previously uneconomic ore.

Neurable's MW75 Neuro headphones, developed with Master & Dynamic, integrate 12-channel soft-fabric EEG sensors into the earcups to deliver real-time metrics including focus, fatigue, calmness, anxiety and cognitive speed throughout the workday.

commercializes its PPFM-based Terrasym line (401 for soybean, 450 for corn), biostimulants that increase nutrient uptake and provide season-long protection against salinity, heat and drought stress.

designated a Jiangsu Provincial Synthetic Biotechnology Innovation Center in 2025, the only institution in Changzhou to receive this provincial recognition that year, backed by a RMB 900 million investment funding an AI-driven molecular design platform and a high-throughput analytical testing facility.

one of the world's three leading vitamin C suppliers, reported in March 2026 that its plants were running at full capacity, with vitamin C and piracetam output up nearly 15% year-on-year in the first two months of the year and core products passing multiple international customer audits.

commissioned by the European Commission, published an April 2026 study led by Michael Carus finding no fundamental technical barriers to using bio-based polymers in plastic packaging, screening 17 bio-based polymer options under the EU's Packaging and Packaging Waste Regulation.

continues expanding its predictive soil-pathogen and nematode testing service, having grown from row-crop pathogen detection into cotton-specific predictive analytics for the US Delta region.

supplies seed-treatment equipment including its MultiCoater CM batch treater, using air-cushion rotor-stator technology for gentle coating and simultaneous drying in a single step, and its Continuous Treater CT delivering up to 25 tonnes/hour with up to four formulas applied simultaneously.

its NanoLuc luciferase platform continues to anchor new research, including a July 2025 study using NanoBiT/NanoBRET tags at endogenous gene loci for cancer protein-protein-interaction reporter cell lines, and a January 2026 paper engineering GFP-NanoLuc BRET fusion substrates for protease-activity detection.

continues expanding its Sustainable Food practice, publishing a June 2026 Sustainable Food Playbook analyzing how food and beverage companies can use sustainability strategy to stabilize margins, supply continuity and portfolio performance amid a volatile operating environment.

continues major mine-closure programs, including demolition, landforming and revegetation at the Argyle diamond mine in Western Australia on track for 2026 completion, alongside staged reclamation planning at the Diavik diamond mine in Canada.

specializes in wheat deep processing, with its NUTRALYS wheat protein hydrolysate (≥83% protein) and textured wheat protein products serving the plant-based meat sector as of its December 2025 product catalog, alongside GLUCIDEX maltodextrin.

Multi-type rare codon recoding — Simultaneous incorporation of up to 5 distinct ncAAs.

based in Shandong province, continues expanding paper production capacity, including a roughly CNY 2 billion investment in a 450,000-tonne/year offset printing paper plant at its Jining base, part of the country's largest private paper holding group with significant bamboo processing lines.

published a 2026 regulatory-science paper proposing a progressive strategy for pre-market immunological evaluation of recombinant collagen medical devices, co-authored with device manufacturers including Gempharmatech, Jiangsu Trautec Medical Technology and Shanghai LabEx Biotech.